SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (131)2/9/1999 10:10:00 AM
From: scaram(o)uche   of 370
 
Jim:

I read the manuscript. I need more info. It looks as though the bug still makes lipid A, but produces it at a markedly reduced level. If the bug produces 1% of the normal levels of lipid A, it doesn't take many divisions until you have the same level of endotoxin.

Not certain that FDA will buy into clinical testing. One spends a lot of time trying to *prevent* chemotherapy patients from getting Gram-negatives.

Good stuff, just not certain that it's practical.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News